FDA Inspection 1137067 — Eurofins Advantar Laboratories, LLC
The FDA completed an inspection of Eurofins Advantar Laboratories, LLC on March 5, 2021 in San Diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 5, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- San Diego, CA (United States)